Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder
Clinical trial NCT07221578 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07221578
- Sponsor
- Vanda Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-22
- Primary completion
- 2026-12-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.